Question 1

Does UBS Asset Management Americas own TGTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Asset Management Americas holds 249,256 shares of TGTX (TG Therapeutics), worth $13.7M.

Question 2

How many shares of TGTX does UBS Asset Management Americas own?

Accepted Answer

As of its Q2 2026 13F, UBS Asset Management Americas holds 249,256 shares of TGTX (TG Therapeutics).

Question 3

What is UBS Asset Management Americas' TGTX position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Asset Management Americas' TGTX position is worth $13.7M.

Question 4

Is UBS Asset Management Americas buying or selling TGTX?

Accepted Answer

In Q2 2026, UBS Asset Management Americas increased its TGTX position by 13,779 shares (+5.9%).

Question 5

When did UBS Asset Management Americas first buy TGTX?

Accepted Answer

UBS Asset Management Americas already held TGTX in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	249,256	+5.8%	$13.7M	0.0%	$54.94	30
2026-Q1	Decreased	235,477	-1.3%	$7.8M	0.0%	$33.22	0
2025-Q4	Decreased	238,686	-2.6%	$7.1M	0.0%	$29.81	0
2025-Q3	Decreased	245,051	-40.1%	$8.9M	0.0%	$36.13	0
2025-Q2	Increased	409,393	+42.6%	$14.7M	0.0%	$35.99	38
2025-Q1	Increased	287,059	+5.4%	$11.3M	0.0%	$39.43	29
2024-Q4	Decreased	272,370	-7.3%	$8.2M	0.0%	$30.10	0
2024-Q3	Decreased	293,927	-8.7%	$6.9M	0.0%	$23.39	0